Sofinnova combines its sector expertise with AWS’s AI and cloud services to help life sciences companies scale faster The collaboration expands Sofinnova’s proprietary AI platform, Sofia, including a new founder-facing version PARIS, France – June 10, 2026 – Sofinnova Partners (“Sofinnova”), a leading European life sciences venture capital firm based in Paris, London, and Milan, […]
Dalton is a drug discovery platform integrating agentic AI, human expertise, and experimental data, into one continuous learning engine Announces collaboration with Sygnature Discovery, a leading integrated drug discovery contract research organisation (CRO), as a client London, UK – 4 June 2026 – DaltonTx, the intelligence backbone for modern drug discovery: connecting AI, human expertise and […]
Last month I went to Copenhagen for the LSX Nordic conference, which was great. The metro ride from the airport to the city centre in a driverless train was a novelty for me, as tube trains on the London Underground all have drivers. I thought no more about it. What if, though, the aeroplane in […]
Collaboration combines Bonito’s proprietary functional delivery data engine and ligand discovery platform with DaltonTx’s adaptive AI technology to accelerate precision oligotherapeutic delivery, beginning in the CNS Waltham, MA and London, UK – May 27th, 2026 – Bonito Biosciences (“Bonito”), a biotechnology company building the data foundation for programmable oligotherapeutic delivery, and”) DaltonTx, the intelligence backbone […]
Round led by Heran Partners and joined by Clave Capital, Inveready and Bio&Tech Smart Capital Financing will enable Pharmacelera to build ongoing relationships with major pharma and biotech customers in the US Pharmacelera’s platform scours vast chemical ‘exaSpace’ accurately for novel molecules Barcelona, Spain, February 18, 2026 – Pharmacelera, a deep tech company applying Quantum […]
